Bacteria found in the gut may "trigger" rheumatoid arthritis in people already at risk for the autoimmune condition Research results
Medical researchers University of Colorado School of Medicine[/B] have discovered that a bacterium found in the gut can "trigger" rheumatoid arthritis in people already at risk for the autoimmune condition
Kristine Kuhn, Associate Professor of Rheumatology and leader of the research team said:
"We found that we can identify people at risk for rheumatoid arthritis based on serological markers and that these markers can be present in the blood for many years before diagnosis.
When we looked at the antibodies, we saw that one is the normal class of antibodies that we see in the bloodstream, but the other is antibodies that we usually associate with the mucosa, mouth, gut or lungs.
We then began to wonder if there was something in the mucosa that could lead to rheumatoid arthritis."
Discovering a new bacterium
Researchers at the University of Colorado, in collaboration with researchers at Stanford University, took antibodies created from immune cells of people whose blood markers indicated they were at risk for the disease and mixed them with the stool of at-risk individuals to find the bacteria that were linked to the antibodies.
To confirm their hypothesis, the researchers used animal models to host the bacteria they discovered.
These experiments showed that the bacteria not only caused the blood markers present in people at risk of rheumatoid arthritis to develop, but some animal models developed full-blown rheumatoid arthritis.
The researchers confirmed that T cells in the blood of people with rheumatoid arthritis respond to these bacteria, but otherwise healthy people do not.
Through studies in humans and animal models, researchers confirmed that these bacteria are associated with the risk of developing rheumatoid arthritis.
They cause a disease similar to rheumatoid arthritis in animal models and in humans, and it appeared that this bacterium triggers immune responses specific to rheumatoid arthritis.
A new target for rheumatoid arthritis
If the unique type of bacteria is indeed responsible for the immune response that leads to rheumatoid arthritis in people already at risk for the disease, Kuhn says, it may be possible to target the bacteria with drugs to prevent that response.
"The next step we want to take is to identify, in larger populations of people at risk for rheumatoid arthritis, whether these bacteria are associated with other genetic, environmental and mucosal immune responses and, ultimately, with the development of rheumatoid arthritis," Kuhn says.
"Then we could say it's a marker useful in predicting who will develop rheumatoid arthritis and implementing prevention strategies. The other possibility is, if we understand how these immune responses are triggered, we might be able to block the ability of the bacteria to cause the disease."
The study lasted five years and involved people who discovered they were at risk for rheumatoid arthritis and volunteered to support the effort.
The researchers want to look at exactly how bacteria trigger this immune response, as well as different methods of blocking this response.
"There are many different technologies that could selectively target a bacterium in the gut microbiome to prevent it, for example, from having an immunogenic effect on the host," Kuhn says.
"For a long time, people thought that antibiotics could be a useful treatment for rheumatoid arthritis, but instead of traditional antibiotics that kill a large group of bacteria, we could selectively target that bacterium or its effects," he concludes.
The findings were published in the scientific journal Science Translational Medicine.
Source: ygeianews,gr
Contents of this article including associated images are belongs Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times
Source